A Quantitative Structure-Activity Relationship and Molecular Modeling Study on a Series of Heteroaryl- and Heterocyclyl-Substituted Imidazo[1,2-a] Pyridine Derivatives Acting as Acid Pump Antagonists

被引:4
作者
Agarwal, Neeraj [1 ]
Bajpai, Anubha [1 ]
Gupta, Satya P. [2 ,3 ]
机构
[1] Meerut Inst Engn & Technol, Dept Biotechnol, Meerut 250005, Uttar Pradesh, India
[2] Meerut Inst Engn & Technol, Dept Pharmaceut Technol, Meerut 250005, Uttar Pradesh, India
[3] Meerut Inst Engn & Technol, Dept Appl Sci, Meerut 250005, Uttar Pradesh, India
关键词
D O I
10.1155/2013/141469
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A quantitative structure-activity relationship (QSAR) and molecular docking study has been performed on a series of heteroary-land heterocyclyl-substituted imidazo[1,2-a] pyridine derivatives acting as acid pump antagonists in order to have a better understanding of the mechanism of H+/K+-ATPase inhibition. The QSAR study shows a significant correlation of activity with Global Topological Charge Indices (GTCI) of the compounds and the hydrophobic constant.. of some substituents, indicating that the charge transfer within the molecule and the hydrophobic property of some substituents will be the controlling factor of the activity of these compounds and that there can be dispersion interaction between the molecules and the receptor, where some substituents may have hydrophobic interaction, too. Based on this correlation some new compounds with higher potency have been predicted and their docking study has been performed to see if they can have better interaction with the receptor. The ADME properties of these predicted compounds have also been reported that follow Lipinski's rule of five.
引用
收藏
页数:15
相关论文
共 19 条
[1]  
Agarwal N., 2013, STRUCT BIOL, V2013, P11
[2]   Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases [J].
Andersson, K ;
Carlsson, E .
PHARMACOLOGY & THERAPEUTICS, 2005, 108 (03) :294-307
[3]   Orally active C-6 heteroaryl- and heterocyclyl-substituted imidazo[1,2-a]pyridine acid pump antagonists (APAs) [J].
Bailey, Nick ;
Bamford, Mark J. ;
Brissy, Delphine ;
Brookfield, Joanna ;
Demont, Emmanuel ;
Elliott, Richard ;
Garton, Neil ;
Farre-Gutierrez, Irene ;
Hayhow, Thomas ;
Hutley, Gail ;
Naylor, Antoinette ;
Panchal, Terry A. ;
Seow, Hui-Xian ;
Spalding, David ;
Takle, Andrew K. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (13) :3602-3606
[4]   The 4-indolyl-2-guanidinothiazoles QSAR study of anti-ulcer activity using quantum descriptors [J].
Borges, EG ;
Takahata, Y .
JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM, 2002, 580 :263-270
[5]  
Borges EG, 2001, J MOL STRUC-THEOCHEM, V539, P245, DOI 10.1016/S0166-1280(00)00794-6
[6]  
Fass R, 2005, ALIMENT PHARM THER, V22, P79, DOI 10.1111/j.1365-2036.2005.02531.x
[7]  
Gupta S.P., 2011, QSAR MOL MODELING
[8]   OMEPRAZOLE - THE 1ST PROTON PUMP INHIBITOR [J].
LINDBERG, P ;
BRANDSTROM, A ;
WALLMARK, B ;
MATTSSON, H ;
RIKNER, L ;
HOFFMANN, KJ .
MEDICINAL RESEARCH REVIEWS, 1990, 10 (01) :1-54
[9]   Developments in the inhibition of gastric acid secretion [J].
Mössner, J ;
Caca, K .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 (08) :469-475
[10]   Insight into the structural requirements of proton pump inhibitors based on CoMFA and CoMSIA studies [J].
Nayana, M. Ravi Shashi ;
Sekhar, Y. Nataraja ;
Nandyala, Haritha ;
Muttineni, Ravikumar ;
Bairy, Santosh Kumar ;
Singh, Kriti ;
Mahmood, S. K. .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2008, 27 (03) :233-243